1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. United States >
  5. Colorado >
  6. Natera Acquires Foresight Diagnostics

M&A Deal Summary

Natera Acquires Foresight Diagnostics

On December 5, 2025, Natera acquired life science company Foresight Diagnostics for 450M USD

Acquisition Highlights
  • This is Natera’s 2nd transaction in the Life Science sector.
  • This is Natera’s largest (disclosed) transaction.
  • This is Natera’s 2nd transaction in the United States.
  • This is Natera’s 1st transaction in Colorado.

M&A Deal Summary
Date 2025-12-05
Target Foresight Diagnostics
Sector Life Science
Buyer(s) Natera
Deal Type Add-on Acquisition
Deal Value 450M USD
Advisor(s) Centerview Partners (Financial)
Wilson Sonsini Goodrich & Rosati (Legal)

Target

Foresight Diagnostics

Boulder, Colorado, United States
Foresight Diagnostics is a precision medicine company developing a novel liquid biopsy test for the measurement of minimal residual disease (MRD) to aid in patient management. Its cell-free DNA testing platform was developed in the labs of two prominent professors at Stanford University and is backed by several major peer-reviewed publications. The company has garnered significant partnering interest from multiple pharmaceutical companies in oncology and is poised for rapid growth. Foresight Diagnostics is headquartered in Boulder, Colorado.

Search 214,239 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Natera

Austin, Texas, United States
Category Company
Founded 2003
Sector Healthcare Services
Employees4,424
Revenue 1.7B USD (2024)
DESCRIPTION

Natera engages in cell-free DNA testing. Natera offers a host of proprietary genetic testing services to inform physicians who care for pregnant women, researchers in cancer including biopharmaceutical companies, and genetic laboratories through its cloud-based software platform. Natera was founded in 2003 and is based in Austin, Texas.

DEAL STATS #
Overall 2 of 2
Sector: Life Science M&A 2 of 2
Type: Add-on Acquisition M&A Deals 1 of 1
State: Colorado M&A 1 of 1
Country: United States M&A 2 of 2
Year: 2025 M&A 1 of 1
Size (of disclosed) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2024-01-22 Invitae - Reproductive Health Assets

San Francisco, California, United States

Invitae's Reproductive Health Assets is engaged in the prenatal screening and carrier screening business. Invitae's Reproductive Health Assets is based in San Francisco, California.

Buy -
Mergr

Solution for

Product

Company

Legal